Head-to-head · WeighScore
Blis MD vs NewSelf
The verdict
NewSelf takes it — 85.6/100 to 72.7/100.
NewSelf grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Blis MD | NewSelf |
|---|---|---|
| WeighScore | 72.7/100 | 85.6/100 |
| Grade | C | B |
| Scorecard rank | #74 | #18 |
| Semaglutide | $139/mo | $100/mo |
| Tirzepatide | $199/mo | $144/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #74 · C
Strengths
- Transparent flat monthly pricing published upfront (139 dollars semaglutide, 199 dollars tirzepatide)
- Free initial virtual consultation with a licensed provider
- Both semaglutide and tirzepatide offered with ongoing provider check-ins
Where it loses points
- Compounding pharmacy is not named publicly
- States served are not listed on the site
- Thin public trust signals (no LegitScript seal or named medical director found)
Graded #18 · B
Strengths
- $100 sema / $144 tirz
- All 50 states, LegitScript-verified
- Both molecules
Where it loses points
- Injection-only
- Labs/monitoring detail sparse
- Limited brand history
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.